T-DXd Reevaluated in HER2-Low/HER2-Negative Breast Cancer After New Trials
Laura Huppert, MD Assistant Professor, Medicine University of California, San Francisco School of Medicine San Francisco, CA CASE SUMMARY A 52-year-old postmenopausal women with a history of T2N0M0 estrogen receptor-positive/progesterone receptor- …